デフォルト表紙
市場調査レポート
商品コード
1312229

脊髄刺激療法市場:製品、適応症、エンドユーザー別-2023~2030年の世界予測

Spinal Cord Stimulation Market by Product, Indication, End-Use - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

出版日: | 発行: 360iResearch | ページ情報: 英文 193 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.41円
脊髄刺激療法市場:製品、適応症、エンドユーザー別-2023~2030年の世界予測
出版日: 2023年06月12日
発行: 360iResearch
ページ情報: 英文 193 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

脊髄刺激療法の世界市場は、2023年にCAGR 9.47%で20億7,546万米ドルが予測され、2030年には39億1,620万米ドルに達するという驚異的な成長を遂げると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界の脊髄刺激療法市場を評価するために不可欠です。ビジネス戦略と製品満足度の主要指標を検証することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます:フォアフロント(F)、パスファインダー(P)、ニッチ(N)、バイタル(V)です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します:

1.市場の浸透度:主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展:有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化:新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向:COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報:主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション:将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします:

1.脊髄刺激療法の世界市場規模および予測は?

2.予測期間中、世界の脊髄刺激療法市場を形成するCOVID-19の阻害要因と影響は?

3.脊髄刺激療法の世界市場において予測期間中に投資すべき製品/セグメント/用途/分野は?

4.脊髄刺激療法の世界市場における競争戦略は?

5.脊髄刺激療法の世界市場における技術動向と規制の枠組みは?

6.脊髄刺激療法の世界市場における主要ベンダーの市場シェアは?

7.脊髄刺激療法の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 失敗した腰症候群と椎間板変性疾患(DDD)の発生率が上昇し、複数回の腰の手術が必要になる
      • 有利な医療償還と機器の承認
      • 腰痛の治療と手術に対する意識の向上
    • 抑制要因
      • 脊髄刺激療法の技術的制限
    • 機会
      • 製品の高機能化に向けた研究開発
      • 非侵襲的な治療と手術への傾向
    • 課題
      • 製品リコールに関する問題
  • 市場動向
  • COVID-19の累積的な影響
  • ロシア・ウクライナ紛争の累積的影響
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み
  • 顧客のカスタマイズ

第6章 脊髄刺激療法市場:製品別

  • イントロダクション
  • 従来の非充電式植込み型パルス発生器
  • 高周波刺激装置
  • 充電式埋め込み型パルス発生器

第7章 脊髄刺激療法市場:適応症別

  • イントロダクション
  • 複合性局所疼痛症候群
  • 腰部手術失敗症候群
  • 虚血性四肢痛

第8章 脊髄刺激療法市場:最終用途別

  • イントロダクション
  • 外来手術
  • クリニック
  • 病院

第9章 南北アメリカの脊髄刺激療法市場

  • イントロダクション
  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域の脊髄刺激療法市場

  • イントロダクション
  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカの脊髄刺激療法市場

  • イントロダクション
  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析:主要企業別
  • 競合シナリオ分析:主要企業別

第13章 掲載企業一覧

第14章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. SPINAL CORD STIMULATION MARKET RESEARCH PROCESS
  • FIGURE 2. SPINAL CORD STIMULATION MARKET SIZE, 2022 VS 2030
  • FIGURE 3. SPINAL CORD STIMULATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
  • FIGURE 5. SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2022 VS 2030 (%)
  • FIGURE 6. SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2022 VS 2030 (%)
  • FIGURE 7. SPINAL CORD STIMULATION MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 8. SPINAL CORD STIMULATION MARKET DYNAMICS
  • FIGURE 9. SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS SPINAL CORD STIMULATION MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES SPINAL CORD STIMULATION MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC SPINAL CORD STIMULATION MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. EUROPE, MIDDLE EAST & AFRICA SPINAL CORD STIMULATION MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. SPINAL CORD STIMULATION MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 17. SPINAL CORD STIMULATION MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. SPINAL CORD STIMULATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. SPINAL CORD STIMULATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 5. SPINAL CORD STIMULATION MARKET SIZE, BY NON-RECHARGEABLE CONVENTIONAL IMPLANTABLE PULSE GENERATOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. SPINAL CORD STIMULATION MARKET SIZE, BY RADIOFREQUENCY STIMULATOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. SPINAL CORD STIMULATION MARKET SIZE, BY RECHARGEABLE IMPLANTABLE PULSE GENERATOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 9. SPINAL CORD STIMULATION MARKET SIZE, BY COMPLEX REGIONAL PAIN SYNDROME, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. SPINAL CORD STIMULATION MARKET SIZE, BY FAILED BACK SURGERY SYNDROME, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. SPINAL CORD STIMULATION MARKET SIZE, BY ISCHEMIC LIMB PAIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 13. SPINAL CORD STIMULATION MARKET SIZE, BY AMBULATORY SURGICAL UNITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. SPINAL CORD STIMULATION MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. SPINAL CORD STIMULATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS SPINAL CORD STIMULATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 26. CANADA SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 29. MEXICO SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 32. UNITED STATES SPINAL CORD STIMULATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 36. ASIA-PACIFIC SPINAL CORD STIMULATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 40. AUSTRALIA SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 43. CHINA SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 46. INDIA SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 49. INDONESIA SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 52. JAPAN SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 55. MALAYSIA SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 58. PHILIPPINES SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 61. SINGAPORE SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 64. SOUTH KOREA SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 67. TAIWAN SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 70. THAILAND SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 73. VIETNAM SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA SPINAL CORD STIMULATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 80. DENMARK SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 83. EGYPT SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 86. FINLAND SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 89. FRANCE SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 92. GERMANY SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 95. ISRAEL SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 98. ITALY SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 101. NETHERLANDS SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 104. NIGERIA SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 107. NORWAY SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 110. POLAND SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 113. QATAR SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 116. RUSSIA SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 119. SAUDI ARABIA SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 122. SOUTH AFRICA SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 125. SPAIN SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 128. SWEDEN SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 131. SWITZERLAND SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 134. TURKEY SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 137. UNITED ARAB EMIRATES SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED KINGDOM SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 143. SPINAL CORD STIMULATION MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 144. SPINAL CORD STIMULATION MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 145. SPINAL CORD STIMULATION MARKET LICENSE & PRICING
目次
Product Code: MRR-0309FBC512F5

The Global Spinal Cord Stimulation Market is forecasted to grow significantly, with a projected USD 2,075.46 million in 2023 at a CAGR of 9.47% and expected to reach a staggering USD 3,916.20 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Spinal Cord Stimulation Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Spinal Cord Stimulation Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Non-Rechargeable Conventional Implantable Pulse Generator, Radiofrequency Stimulator, and Rechargeable Implantable Pulse Generator. The Non-Rechargeable Conventional Implantable Pulse Generator commanded largest market share of 48.11% in 2022, followed by Radiofrequency Stimulator.

Based on Indication, market is studied across Complex Regional Pain Syndrome, Failed Back Surgery Syndrome, and Ischemic Limb Pain. The Complex Regional Pain Syndrome commanded largest market share of 21.67% in 2022, followed by Failed Back Surgery Syndrome.

Based on End-Use, market is studied across Ambulatory Surgical Units, Clinics, and Hospitals. The Hospitals commanded largest market share of 82.12% in 2022, followed by Clinics.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded largest market share of 43.68% in 2022, followed by Americas.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Spinal Cord Stimulation Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Spinal Cord Stimulation Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Spinal Cord Stimulation Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Spinal Cord Stimulation Market?

4. What is the competitive strategic window for opportunities in the Global Spinal Cord Stimulation Market?

5. What are the technology trends and regulatory frameworks in the Global Spinal Cord Stimulation Market?

6. What is the market share of the leading vendors in the Global Spinal Cord Stimulation Market?

7. What modes and strategic moves are considered suitable for entering the Global Spinal Cord Stimulation Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Spinal Cord Stimulation Market, by Product, 2022 vs 2030
  • 4.3. Spinal Cord Stimulation Market, by Indication, 2022 vs 2030
  • 4.4. Spinal Cord Stimulation Market, by End-Use, 2022 vs 2030
  • 4.5. Spinal Cord Stimulation Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidence of failed back syndrome and degenerative disk disease (DDD) and need for multiple back surgeries
      • 5.1.1.2. Favorable medical reimbursements and approvals for device
      • 5.1.1.3. Increasing awareness about back pain treatments and surgeries
    • 5.1.2. Restraints
      • 5.1.2.1. Technical limitations of spinal cord stimulation
    • 5.1.3. Opportunities
      • 5.1.3.1. R&D for advancement in product functionality
      • 5.1.3.2. Inclination towards non-invasive treatments and surgeries
    • 5.1.4. Challenges
      • 5.1.4.1. Issues related to product recalls
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Spinal Cord Stimulation Market, by Product

  • 6.1. Introduction
  • 6.2. Non-Rechargeable Conventional Implantable Pulse Generator
  • 6.3. Radiofrequency Stimulator
  • 6.4. Rechargeable Implantable Pulse Generator

7. Spinal Cord Stimulation Market, by Indication

  • 7.1. Introduction
  • 7.2. Complex Regional Pain Syndrome
  • 7.3. Failed Back Surgery Syndrome
  • 7.4. Ischemic Limb Pain

8. Spinal Cord Stimulation Market, by End-Use

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Units
  • 8.3. Clinics
  • 8.4. Hospitals

9. Americas Spinal Cord Stimulation Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Spinal Cord Stimulation Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Spinal Cord Stimulation Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing